Oramed Pharmaceuticals

(NASDAQ) ORMP

Current Price$3.94

Market Cap$160.98M

Since IPO (2004)+2,248%

5 Year-60%

1 Year+88%

1 Month+17%

Oramed Pharmaceuticals Financials at a Glance

Market Cap

$160.98M

Revenue (TTM)

$2.00M

Net Income (TTM)

$75.32M

EPS (TTM)

$1.49

P/E Ratio

2.68

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$3.94

Volume

4,009

Open

$3.97

Price

$3.94

Volume

4,009

Open

$3.97

Previous Close

$3.94

Daily Range

$3.94 - $3.99

52-Week Range

$1.98 - $4.22

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$3.94

Volume

4,009

Open

$3.97

Previous Close

$3.94

Daily Range

$3.94 - $3.99

52-Week Range

$1.98 - $4.22

ORMP News

Why Oramed Pharmaceuticals, Millennial Media, and Xoom Are Today's 3 Best Stocks

Sean WilliamsJan 27, 2014

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oramed Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Nadav Kidron, MBA

Website

www.oramed.com

Headquarters

New York City, NY 10036, US

ORMP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

-8%

Net Income Margin

38%

Return on Equity

37%

Return on Capital

-19%

Return on Assets

77%

Earnings Yield

37.31%

Dividend Yield

0.00%

Payout Ratio

14.43%

Stock Overview

Market Cap

$160.98M

Shares Outstanding

40.45M

Volume

4.01K

Avg. Volume

139.66K

Financials (TTM)

Gross Profit

$13.00K

Operating Income

$15.09M

EBITDA

$15.09M

Operating Cash Flow

$9.14M

Capital Expenditure

$9.00K

Free Cash Flow

$9.15M

Cash & ST Invst.

$51.36M

Total Debt

$825.00K

Oramed Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$61.00K

+296.8%

Gross Margin

0.00%

N/A

Market Cap

$160.98M

N/A

Market Cap/Employee

$12.38M

N/A

Employees

N/A

Net Income

$21.28M

+308.9%

EBITDA

$83.26M

-753.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$50.54M

-64.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$540.00K

+246.2%

Short Term Debt

$285.00K

+31.9%

Return on Assets

77.18%

N/A

Return on Invested Capital

-19.22%

N/A

Free Cash Flow

$4.05M

-108.2%

Operating Cash Flow

$4.05M

-109.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IFRXInflaRx N.V.

IFRXInflaRx N.V.$2.10+1.45%

CNTBConnect Biopharma Holdings Limited

CNTBConnect Biopharma Holdings Limited$2.47+0.00%

MGNXMacroGenics, Inc.

MGNXMacroGenics, Inc.$3.13+1.62%

CNTXContext Therapeutics Inc.

CNTXContext Therapeutics Inc.$2.27-3.81%

KLRSKalaris Therapeutics Inc

KLRSKalaris Therapeutics Inc$5.46-1.09%

COYACoya Therapeutics, Inc.

COYACoya Therapeutics, Inc.$4.17-1.42%

IMAImageneBio Inc

IMAImageneBio Inc$5.66-5.98%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About ORMP

What is the current price of Oramed Pharmaceuticals?

Oramed Pharmaceuticals is trading at $3.94 per share.

What is the 52-week range for Oramed Pharmaceuticals?

Over the past 52 weeks, Oramed Pharmaceuticals has traded between $1.98 and $4.22.

How much debt does Oramed Pharmaceuticals have?

As of the most recent reporting period, Oramed Pharmaceuticals reported total debt of $825,000.

How much cash does Oramed Pharmaceuticals have on hand?

Oramed Pharmaceuticals reported $45.95M in cash and cash equivalents in its most recent financial results.

What is Oramed Pharmaceuticals’s dividend yield?

Oramed Pharmaceuticals does not currently have a dividend yield.

Oramed Pharmaceuticals

Oramed Pharmaceuticals Financials at a Glance

ORMP News

Why Oramed Pharmaceuticals Stock Is Crashing Today

Why Oramed Pharmaceuticals Stock Is On Fire Today

Why Oramed Pharmaceuticals Stock Rocketed Higher Today

Oramed Pharmaceuticals: Monday’s Top Stock

Why Oramed Pharmaceuticals, Millennial Media, and Xoom Are Today's 3 Best Stocks

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Oramed Pharmaceuticals

ORMP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Oramed Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ORMP

What is the current price of Oramed Pharmaceuticals?

What is the 52-week range for Oramed Pharmaceuticals?

How much debt does Oramed Pharmaceuticals have?

How much cash does Oramed Pharmaceuticals have on hand?

What is Oramed Pharmaceuticals’s dividend yield?

Premium Investing Services